Inhibition of FEN1 Increases Arsenic Trioxide-Induced ROS Accumulation and Cell Death: Novel Therapeutic Potential for Triple Negative Breast Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00425
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer

2012English

Therapeutic Advances and New Directions for Triple-Negative Breast Cancer

Breast Care
SurgeryOncology
2017English

Arsenic Trioxide Induces Human Pulmonary Fibroblast Cell Death via Increasing ROS Levels and GSH Depletion

Oncology Reports
MedicineCancer ResearchOncology
2012English

Therapeutic Landscape in Mutational Triple Negative Breast Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2018English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

Triple-Negative Breast Cancer

2018English

Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple Negative Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

7. PD-L1 in Triple Negative Breast Cancer – Optimal Testing for Therapeutic Efficacy

Pathology
Forensic MedicinePathology
2020English

Identification of New Candidate Therapeutic Target Genes in Triple-Negative Breast Cancer

Genes and Cancer
Cancer ResearchGenetics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy